Bioserve Biotechnologies (India) Private Limited, a active private limited company, was established on 21 February 1994 in Uppal, Telangana, India. Engaging in biotechnology within the manufacturing sector, it holds CIN: U72200TG1994PTC017063. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹12.50 Cr and a paid-up capital of ₹12.21 Cr.
It upholds a compliant status. Employing 28 professional, Its leadership includes Venkateswarlu Prathipati (Director), Chikafumi Yokoyama (Director), Daisuke Usui (Director). Past directors included Venkateswarlu Prathipati, Modali Venkatasiva Ramakrishna, Joe Thomas Mangalam. It holds no open charges and ₹1.08 Cr settled loans. Its latest AGM occurred on 18 August 2025, with the balance sheet filed on 31 March 2025. It is based at Pinnacle Towers, 1St Floor, Plot No. 9/17/A&B, Road No. 6, Ida Nacharam, Uppal, Telangana, 500076.
U72200TG1994PTC017063
017063
21 February 1994
₹12.50 Cr
₹12.21 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Bioserve Biotechnologies (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkateswarlu Prathipati | Director | 23 Feb 2017 | Current |
| Chikafumi Yokoyama | Director | 07 Oct 2020 | Current |
| Daisuke Usui | Director | 16 Dec 2020 | Current |
| Bhawna Dubey | Director | 01 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
| Pramod Abcsdd | Director | 08 Aug 2023 | Past |
| Pramod Abcsdd | Managing Director | 31 Aug 2011 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 04 Sep 2019 | Past |
| Pramod Abcsdd | Whole-Time Director | 06 Jan 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bioserve Biotechnologies (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.62% increase. The company also saw a substantial improvement in profitability, with a 34.77% increase in profit. The company's net worth observed a substantial decline by a decrease of 26.15%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Bioserve Biotechnologies (India) had a promoter holding of 99.56% and a public holding of 0.44%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹10,750,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Dec 2012 | Jain Sons Finlease Limited | ₹7.50 M | Satisfied |
| 31 Dec 2007 | Ventureast Trustee Company Private Limited | ₹0.75 M | Satisfied |
| 26 Dec 2002 | State Bank Of Hyderabad | ₹2.50 M | Satisfied |
Explore comprehensive loan charge details -
Bioserve Biotechnologies (India) has a workforce of 28 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Bioserve Biotechnologies (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioserve Biotechnologies (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Bioserve Biotechnologies (India) Private Limited last Annual general meeting of members was held on 18 Aug 2025 as per latest MCA records. was completed.
Progress on Aashi Lalit Shah was appointed as a Company Secretary was appointed as a Company Secretary on 19 May 2025 & has been associated with this company since 6 months 18 days . was documented.
The activity Bhawna Dubey was appointed as a Director was appointed as a Director on 01 Apr 2025 & has been associated with this company since 8 months 4 days . was completed.
Progress on Bioserve Biotechnologies (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
Daisuke Usui was appointed as a Director was appointed as a Director on 16 Dec 2020 & has been associated with this company since 4 years 11 months . was recorded as a recent event.
Chikafumi Yokoyama was appointed as a Director was appointed as a Director on 07 Oct 2020 & has been associated with this company since 5 years 1 month . was recorded as a recent event.
The CIN of Bioserve Biotechnologies (India) Private Limited is U72200TG1994PTC017063.
Bioserve Biotechnologies (India) Private Limited is headquartered at Pinnacle Towers, 1St Floor, Plot No. 9/17/A&B, Road No. 6, Ida Nacharam, Uppal, Telangana, 500076.
Bioserve Biotechnologies (India) Private Limited was incorporated on 21 February 1994.
The current directors of Bioserve Biotechnologies (India) Private Limited are
The primary industry of Bioserve Biotechnologies (India) Private Limited is Manufacturing.
Bioserve Biotechnologies (India) Private Limited is unlisted.
The authorized capital of Bioserve Biotechnologies (India) Private Limited is ₹12.50 Cr, and the paid-up capital is ₹12.21 Cr.
The compliance status of Bioserve Biotechnologies (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX